Tiger milk mushroom shows genuine promise for lung health, with laboratory, animal, and early human research pointing to anti-inflammatory, airway-relaxing, and immune-boosting effects. Indigenous communities in Southeast Asia, China, and Australia have used it for generations to treat cough, asthma, and bronchitis. Modern science is now catching up to those traditional claims, though most of the strongest evidence still comes from animal studies rather than large human trials.
What Tiger Milk Mushroom Does in the Airways
The part of tiger milk mushroom used medicinally is the sclerotium, a dense underground mass packed with bioactive compounds. These include beta-glucans, polysaccharide-protein complexes, phenolic compounds, and specialized proteins called fungal immunomodulatory proteins. Together, these compounds appear to work on the lungs through several distinct pathways.
The most relevant for respiratory health is airway relaxation. Lab studies using isolated airway tissue from rats found that extracts of the mushroom relaxed pre-contracted airways in a dose-dependent manner. Higher molecular weight fractions of the extract were more effective at opening up airways than lower molecular weight fractions. Interestingly, this relaxation effect doesn’t work through the same pathway as standard bronchodilator inhalers. Instead, it appears to block calcium channels that trigger airway muscles to contract, and it also modulates receptors involved in histamine and cholinergic responses. That means it could complement, rather than duplicate, conventional asthma medications.
Effects on Airway Inflammation
Chronic lung conditions like asthma involve a cycle of inflammation, excess mucus, and hypersensitive airways. Animal studies show tiger milk mushroom interrupts this cycle at multiple points. In mice with induced asthma, treatment significantly reduced airway hyperresponsiveness at doses of 125, 250, and 500 mg/kg. The extract also lowered levels of key inflammatory signals (IL-4, IL-5, and IL-13) that drive the allergic immune response in asthma.
Mucus overproduction is another hallmark of asthma and bronchitis. In the same mouse model, the mushroom extract significantly reduced mucus production, performing comparably to dexamethasone, a standard anti-inflammatory steroid. It also decreased the infiltration of immune cells into the tissue surrounding the airways, which is what causes swelling and narrowing during an asthma flare. Notably, 16 genes linked to asthma were upregulated in sensitized mice, and treatment with the extract downregulated those same genes.
An early human study found that tiger milk mushroom supplementation significantly reduced levels of two inflammatory markers: IL-1β, which promotes tissue injury and scarring in the lungs, and IL-8, which recruits immune cells called neutrophils to the airways. Neutrophil-driven inflammation plays a major role in severe asthma and COPD.
Immune and Antioxidant Support
Beyond calming inflammation, tiger milk mushroom appears to strengthen the body’s frontline respiratory defenses. Human supplementation increased levels of IgA, an antibody that protects the mucosal surfaces of the lungs, nose, and throat. Higher IgA means better day-to-day defense against inhaled pathogens and irritants.
The mushroom also boosted total antioxidant capacity in human subjects. Oxidative stress, essentially an imbalance between harmful free radicals and the body’s ability to neutralize them, contributes to tissue damage in both asthma and COPD. One study measured MDA, a marker of oxidative damage, and found that tiger milk mushroom significantly suppressed its production. This protective effect likely comes from the mushroom’s high phenolic content. Polyphenols reduce inflammation by calming stress signals inside cells and blocking the production of inflammatory compounds.
What About COPD?
COPD involves irreversible narrowing of the airways, which makes it fundamentally different from asthma. While the airway-relaxing and anti-inflammatory properties of tiger milk mushroom are theoretically relevant to COPD, researchers have been cautious. As one review in Frontiers in Pharmacology noted, “there is limited scientific evidence to support its therapeutic effects” for COPD specifically. The antioxidant and anti-inflammatory actions could help manage some symptoms, but no clinical trials have tested the mushroom in COPD patients. If you have COPD, the existing evidence isn’t strong enough to guide treatment decisions.
Dosage Used in Research
A Phase II clinical trial registered on ClinicalTrials.gov for uncontrolled asthma used a specific protocol: 500 mg per day (two 250 mg capsules, once daily with meals) for the first four weeks, then escalated to 1,000 mg per day (two 250 mg capsules, twice daily) for the following eight weeks. This 12-week regimen is the closest thing to a standardized human dosage available in the published literature. Most commercial supplements fall within or near this range.
Safety Profile
Tiger milk mushroom has a reassuring safety record in toxicity testing. A 13-week study gave rats doses up to 3,400 mg per kilogram of body weight daily, far exceeding any human supplement dose. All animals survived with no abnormal changes in clinical signs, body weight, blood work, organ appearance, or tissue under a microscope. The no-observed-adverse-effect level was set above that highest dose, which is a strong signal of low toxicity.
Human safety data is more limited. The clinical trials that have been conducted reported no significant adverse effects, but these involved relatively small groups of participants over weeks, not months or years. The mushroom has a long history of traditional use, which adds some confidence, but formal long-term human safety studies are still lacking.
Where the Evidence Stands
The case for tiger milk mushroom and lung health is built on a solid foundation of lab and animal research, backed by a small but growing number of human studies. It reduces airway inflammation, relaxes constricted airways through a unique mechanism, lowers oxidative damage, and strengthens mucosal immunity. For people with asthma or chronic respiratory inflammation, it’s one of the more scientifically supported medicinal mushrooms available. The main limitation is scale: most human data comes from small trials, and large, placebo-controlled studies are still in progress. It is not a replacement for prescribed inhalers or other medications, but the evidence supports its potential as a complementary supplement for respiratory health.